UXL

A positioning practice for life sciencesSoftwareCROsBiotech

The copy-paste test

Can you tell them apart?

Three life sciences homepages, logos removed. One of them is a company you compete with.

Benchmark of 18 life sciences SaaS homepages · September 2026

LIMS eClinical RWD
Eighteen homepages, read side by side. Seventeen share a structure.
1 of 18

In five words

Commercial translation for life sciences

We translate the scientific advantage of life sciences companies into commercial messaging that buyers understand, trust, and act on — in a four-week sprint.

Life sciences companies communicate like scientists when they need to communicate like businesses.

It is where pipeline stalls, deals take twice as long as they should, and genuinely transformative innovations fail to reach the market they deserve. Not a branding problem. Not a content problem. A translation problem.

The science is real.

The differentiation is real.

Nobody outside the company can see it.

The translation gap

The distance between what you know and what your buyers understand.

What you know What they understand

The Commercial Translation Method

A four-week sprint that turns scientific advantage into a commercial messaging architecture. Built for how pharma procurement evaluates CROs, how lab directors choose platforms, and how investors filter biotech decks.

  1. 01

    Decision Context Diagnostic

    How your specific buyers decide, what alternatives they weigh, and what kind of proof they need. Everything downstream is calibrated to this.

  2. 02

    Science-to-Signal Filter

    Strips out the technical claims that are table stakes and surfaces only what genuinely separates you from the alternative.

  3. 03

    Message Architecture

    Positioning, value propositions, sales narratives and website copy direction — one source of truth for every deck, email and conversation.

  4. 04

    Activation

    Competitive positioning, audience-specific messaging and proof architecture, all production-ready on the day it lands.

The Science-to-Signal Filter, drawn: every claim you could make, reduced to the few that exclude a competitor.
Every claim you could make The ones that exclude a competitor

Prospects understand the differentiation in thirty seconds.

Sales conversations move faster.

Investors see the commercial potential without needing it explained.

Built for

Life sciences software — LIMS, ELN, EDC, eClinical, RWD, QMS — post-seed to Series B, roughly 15 to 80 people

Specialist CROs, roughly 50 to 500 people, competing with larger CROs for the same sponsors

Teams whose science is genuinely differentiated and whose messaging isn't

Teams that have just raised, just hired their first marketer or commercial lead, or just lost a deal or an RFP they should have won

Not for

Companies outside life sciences. This is the whole business, not a vertical we also serve.

Teams looking for a campaign, a rebrand or a content retainer

Anyone who needs the differentiation invented rather than found

One product

€10,000

Four weeks, fixed scope. Everything else has to be earned.

What's included, and what unlocks afterwards →

Two minutes

Do you have a positioning problem?

Check whatever is true. Nothing is sent anywhere.

The teardown

Thirty minutes,
no deck

Bring your homepage. We’ll look at what a buyer sees in the first thirty seconds, and at what your three closest competitors say on the same page.

  • 30minutes, not an hour
  • 0slides, either way
  • 1homepage, read out loud

You’ll leave with something useful whether or not we work together.